期刊文献+

类风湿关节炎并发肺间质纤维化(附25例报告) 被引量:13

Interstitial pulmonary fibrosis in rheumatoid arthritis(report of 25 cases)
下载PDF
导出
摘要 目的探讨类风湿关节炎(RA)并发肺间质纤维化的发生情况、临床特点、肺功能、影像学检查及相关因素,加深对RA肺间质病变的认识。方法回顾我院2002年1月至2006年1月161例住院RA患者的临床资料,包括类风湿因子(RF)、血气分析、胸部X线、肺高分辨CT(HRCT)、肺功能检查等。分析RA并发肺间质纤维化患者的特点。结果本组类风湿关节炎患者中并发肺间质纤维化25例.占全部类风湿关节炎的15%;25例RA并发肺间质纤维化者中,RF强阳性18例,ESR增高23例,CRP增高19例,血小板增高14例,低氧血症18例,23例患者呼吸系统疾患出现在关节炎之后:肺间质纤维化的发生与重症类风湿关节炎有关联,但病情较原发性肺纤维化轻,经过适当的治疗,病情一般能够得到控制,只有3例死亡,占12%,死亡原因为Ⅰ型呼吸衰竭。结论RA患者应尽早做肺HRCT及肺功能检查,以早期诊断和治疗肺部病变,尤其是RF强阳性的RA患者。 Objective To explore the occurrence, clinical characteristics, pulmonary function, radiographic findings and the associated factors of pulmonary interstitial fibrosis in rheumatoid arthritis(RA) to build up knowledge for early diagnosis. Methods The clinical data of 161 admitted RA patients from January 2002 to January 2006 were analyzed retrospectively including rheumatoid factor(RF),blood-gas analysis,chest X-ray,chest HRCT,pulmonary function tests. Results 25 RA patients concurring with interstitial pulmonary fibrosis(IPF) accounted for 15% of total RA patients. Among the 25 RA patients with IPF, 18 cases were with strongly positive RF, 23 cases with elevated ESR, 19 cases with elevated CRP, 14 cases with elvated platelets account and 18 cases with hypoxemia. Respiratory symptoms presented after the joint symptoms. IPF was related to the severity of rheumatoid arthritis. When treated appropriately, IPF secondary to RA could be well controlled. Only 3 deaths occurred in this study with the mortality of 12%. The cause of the death was type Ⅰ respiratory failure. Conclusions HRCT and pulmonary function test should be taken early in order to get early diagnosis and treatment, especially in those with strongly positive RF.
出处 《北京医学》 CAS 2006年第10期593-595,共3页 Beijing Medical Journal
关键词 类风湿关节炎 肺间质纤维化 Rheumatoid arthritis(RA) Interstitial pulmonary fibrosis(IPF)
  • 相关文献

参考文献11

  • 1蒋明等主编..中华风湿病学[M].北京:华夏出版社,2004:2036.
  • 2Amett FC,Edworth SM,Bloch DA,et al.The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.American Rheum,1988,31:321-324. 被引量:1
  • 3AST/ERS.Idiopathic pulmonary fibrosis:diagnosis and treatment international consensus statement.Am J Respir Crit Care Med,2000,161:646-664. 被引量:1
  • 4张乃峥.风湿性疾病的分类.见:方圻,主编.现代内科学.北京:人民军医出版社.1995:3157-3159. 被引量:1
  • 5Veeraraghavan S,Nicbolson AG,Wells AU,et al.Lung fibrosis:new classifications and therapy.Curr Opin Rheumatol,2001,13:500 -504. 被引量:1
  • 6Vassallo R,Thomas CF.Advances in treatmant of rheumatic interstitial lung disease.Curr Opin Rheumato,2004,16:186-191. 被引量:1
  • 7李海云,郑毅.结缔组织病合并间质性肺疾病的研究进展[J].中华风湿病学杂志,2005,9(7):438-441. 被引量:28
  • 8Cortet B,Flipo RM,Remy-Jardin M,et al.Use of high resolution computed tomography of the lung in patients with rheumatoid arthritis.Ann Rheum Dis,1995,54:815-819. 被引量:1
  • 9Raghu G,Mageto YN,Lockart D,et al.The accuracy of the clinical diagnosis of new-onest idiopathic pulmonary fibrosis and other interstitial lung disease:a prospective study.Chest,1999,116:1168-1174. 被引量:1
  • 10Selman M,Thannichal VJ,Pardo A,et al.Idiopathic puhmonary fibrosis.Drugs,2004,64:405-430. 被引量:1

二级参考文献16

  • 1Veeraraghavan S, Nicholson AG, Wells AU, et al. Lung fibrosis:new classifications and therapy. Curr Opin Rheumatol, 2001, 13:500-504. 被引量:1
  • 2Vassallo R, Thomas CF. Advances in treatment of rheumatic interstitial lung disease. Curr Opin Rheumatol, 2004, 16: 186-191. 被引量:1
  • 3Latsi PI, Wells AU. Evaluation and management of alveolitis and interstitial lung disease in scleroderma. Curr Opin Rheumatol,2003, 15: 748-755. 被引量:1
  • 4MacDonald SLS, Rubens MB, Hansell DM, et al. Nonspecific interstitial pnermonia and usual interstitial pneumonia:comparative appearances and diagnostic accuracy of high-resolution computed tomography. Radiology, 2001, 221: 600-605. 被引量:1
  • 5Cheema GS, Quismorio FP Jr. Interstitial lung disease in systemic sclerosis. Curr Opin Pulm Med, 2001, 7: 283-290. 被引量:1
  • 6Steen VD, Conte C, Owens GR, et al. Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum, 1994, 37: 1283-1289. 被引量:1
  • 7Witt C, Borges AC, John M, et al. Pulmonary involvement in diffuse cutaneous systemic sclerosis: bronchoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis. Ann Rheum Dis, 1999, 58: 635-640. 被引量:1
  • 8Selman M, Thannichal V J, Pardo A, et al. Idiopathic pulmonary fibrosis. Drugs, 2004, 64: 405-430. 被引量:1
  • 9Palas I, Ioannidis JA, Malagari K, ct al. Cyclophosphamide with low or high dose prednisolone for systemic sclerosis lung disease.J Rheumatol, 2002, 29: 298-304. 被引量:1
  • 10Griffiths B, Miles S, Moss H, et al. Systemic sclerosis and interstitial lung disease:a pilot study using pulse intravenous methylprednisolone and cyclophosphamide to assess the effect on high resolution computed tomography scan and lung function. JRheumatol, 2002, 29: 2371-2378. 被引量:1

共引文献27

同被引文献98

引证文献13

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部